Deleted Tweets From Scott Gottlieb, R-D.C.

We’re continuing to actively explore whether we can release redacted copies of “Complete Response Letters.” If we’re going to use a lot of #FDA resources to redact/release CRLs; then the ones we release have to clearly serve important public health goals:

RT @FDAfood: Priorities for 2018 include helping consumers make better & informed decisions when it comes to diets & health. All… https://t.co/zNGVE6Wphv

#FDA and DoD launch new program to expedite availability of medical products for the emergency care of American military personnel https://t.co/LuJG1Ed2mW

'FDA is taking steps to make it easier for doctors, patients and researchers to get access to clinical trial data amassed during the process of approving new drugs.' with a program 'to release clinical study reports for recently approved drugs' https://t.

Enjoyed the opportunity to catch up with @drJoshS who made transparency a priority at #FDA under his leadership. Thank you for hosting me today at PEW to discus the topic and for your efforts. We're fully committed to continuing to embrace and promote tra

RT @FDAMedia: FDA and DoD launch program to expedite availability of medical products for the emergency care of American military… https://t.co/KrkAQwilN7

#FDA’S 2018 STRATEGIC POLICY ROADMAP: Priorities include helping consumers make better and more informed decisions when it comes to diets and health. All part of the FDA’s Healthy Innovation, Safer Families https://t.co/uSafvlUMYc

RT @JohnsHopkinsSPH: "The @US_FDA is taking steps to make it easier for doctors, patients and researchers to get access to clinical tria… https://t.co/j8JiGZkuAu

RT @FDAMedia: FDA Commissioner @SGottliebFDA on new steps @US_FDA is taking to enhance transparency of clinical trial information… https://t.co/Wv164QxgiJ

RT @PubHlthPractice: @drJoshS wraps up today's @JohnsHopkinsSPH symposium on Transparency at the @US_FDA. Thanks to to all our distingu… https://t.co/W6JXW7DJQY

RT @steveusdin1: Gottlieb reveals pilot program for clinical data transparency https://t.co/odN1Hz3KfF

#FDA’s CRL initiative is part of a sustainable framework focused on clinical and patient benefits and is a first key step. But our Transparency must support a strong public health rationale and not only desires of ancillary stakeholders. We are not the SE

Remember: to redact and make public a CRL requires a significant commitment of agency resources. If we’re going to use our valuable resources it must always be in support of a public health purpose

RT @MilitaryHealth: The @DeptofDefense and @US_FDA have announced a partnership to help the Military Health System equip troops with th… https://t.co/jLY9Vpw8f3

#FDA, CDC & others continue to investigate Salmonella illnesses linked to imported frozen shredded coconut. Our state partner @MassDPH made significant progress & matched recalled product identified in outbreak w/strain of Salmonella. Read our upd

RT @CDCgov: #Flu spreads easily and can result in serious health complications. Take action against flu to help protect yoursel… https://t.co/Avc4K3o8I3

Learn about #FDA’s device review program’s priorities for 2018-2020, which will allow timely patient access to high-quality, safe, and effective medical devices. https://t.co/1rKxzO3bPL

RT @FDAWomen: Mammography saves lives. Schedule your #mammogram today. Find a certified mammography facility near you: https://t.co/9rqU9YC0W5

Collecting @megtirrell data points to try and re-assemble the clinical submission https://t.co/2l5aSginJx QT @megtirrell: Thanks for my first official #JPM18 fist bump @JebKeiper!)

New FDA Guidance: Compounded Drug Products That Are Essentially Copies of Approved Drug Products Under FDCA 503B - https://t.co/3xSpVoWY4i

We’re continuing to actively explore whether we can release redacted copies of “Complete Response Letters.” If we’re going to use a lot of #FDA resources to redact/release CRLs; then the ones we release have to clearly serve important public health goals:

RT @FDAfood: Priorities for 2018 include helping consumers make better & informed decisions when it comes to diets & health. All… https://t.co/zNGVE6Wphv

#FDA and DoD launch new program to expedite availability of medical products for the emergency care of American military personnel https://t.co/LuJG1Ed2mW

'FDA is taking steps to make it easier for doctors, patients and researchers to get access to clinical trial data amassed during the process of approving new drugs.' with a program 'to release clinical study reports for recently approved drugs' https://t.

Enjoyed the opportunity to catch up with @drJoshS who made transparency a priority at #FDA under his leadership. Thank you for hosting me today at PEW to discus the topic and for your efforts. We're fully committed to continuing to embrace and promote tra

RT @FDAMedia: FDA and DoD launch program to expedite availability of medical products for the emergency care of American military… https://t.co/KrkAQwilN7

#FDA’S 2018 STRATEGIC POLICY ROADMAP: Priorities include helping consumers make better and more informed decisions when it comes to diets and health. All part of the FDA’s Healthy Innovation, Safer Families https://t.co/uSafvlUMYc

RT @JohnsHopkinsSPH: "The @US_FDA is taking steps to make it easier for doctors, patients and researchers to get access to clinical tria… https://t.co/j8JiGZkuAu

RT @FDAMedia: FDA Commissioner @SGottliebFDA on new steps @US_FDA is taking to enhance transparency of clinical trial information… https://t.co/Wv164QxgiJ

RT @PubHlthPractice: @drJoshS wraps up today's @JohnsHopkinsSPH symposium on Transparency at the @US_FDA. Thanks to to all our distingu… https://t.co/W6JXW7DJQY

RT @steveusdin1: Gottlieb reveals pilot program for clinical data transparency https://t.co/odN1Hz3KfF

#FDA’s CRL initiative is part of a sustainable framework focused on clinical and patient benefits and is a first key step. But our Transparency must support a strong public health rationale and not only desires of ancillary stakeholders. We are not the SE

Remember: to redact and make public a CRL requires a significant commitment of agency resources. If we’re going to use our valuable resources it must always be in support of a public health purpose

RT @MilitaryHealth: The @DeptofDefense and @US_FDA have announced a partnership to help the Military Health System equip troops with th… https://t.co/jLY9Vpw8f3

#FDA, CDC & others continue to investigate Salmonella illnesses linked to imported frozen shredded coconut. Our state partner @MassDPH made significant progress & matched recalled product identified in outbreak w/strain of Salmonella. Read our upd

RT @CDCgov: #Flu spreads easily and can result in serious health complications. Take action against flu to help protect yoursel… https://t.co/Avc4K3o8I3

Learn about #FDA’s device review program’s priorities for 2018-2020, which will allow timely patient access to high-quality, safe, and effective medical devices. https://t.co/1rKxzO3bPL

RT @FDAWomen: Mammography saves lives. Schedule your #mammogram today. Find a certified mammography facility near you: https://t.co/9rqU9YC0W5

Collecting @megtirrell data points to try and re-assemble the clinical submission https://t.co/2l5aSginJx QT @megtirrell: Thanks for my first official #JPM18 fist bump @JebKeiper!)

New FDA Guidance: Compounded Drug Products That Are Essentially Copies of Approved Drug Products Under FDCA 503B - https://t.co/3xSpVoWY4i